PARSIPPANY, N.J., Feb. 3, 2022 /PRNewswire/ -- Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount.
Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer. Dr. Sanghvi brings significant R&D experience to PAI with over 30 years in the pharmaceutical industry which have resulted in the development and launch of over 100 generic products, a dozen branded and specialty products, and numerous ANDA first-to-file applications. In his new role, Dr. Sanghvi will lead PAI's Research and Development (R&D) efforts which are focused on oral liquid and sterile injectable products.
Enforcement Report - Week of February 5, 2020
Enforcement Report - Week of June 13, 2018